Annual Report 2022
Department of Intensive Care Medicine
Ryohei Serita
Introduction
The Department of Intensive Care Medicine came into existence on November 1, 2016. The mission of our department is to provide safe and efficient care for postoperative patients and critically ill patients. In step with the aging of the population, patients with cancer are at higher risk of complications at the pretreatment evaluation. Therefore, high-quality care is needed to ensure efficient procedures. We believe that our department plays a pivotal role in safe and efficient care for patients within the National Cancer Center Hospital East. We are working with the aim of further enhancing such care.
The Team and What We Do
Our clinical focus is to manage the eight-bed intensive care unit (ICU) and provide specialist advice to the attending physicians for all critically ill patients. Since the facility standards were met, intensive care addition has also been calculated from September 2019. The number of patients admitted to the ICU was 1,563 in 2022, almost the same as the previous year. The reasons for ICU admission are shown in Table 1. The utilization rate of ICU beds was 92.1% throughout this year.
Table 1. Main Reasons for ICU Admission (April 2022 - March 2023)
Research Activities
Our research interests include magnesium ion homeostasis of cancer patients. Several studies are in the planning stage.
Clinical Trials
Currently, the department has no clinical trials.
Future Prospects
The objective of our department is to establish an ICU that plays a functional role in offering highly intensive care for patients with cancer. We will work to further define and refine our effort in providing high-quality care.